Here are commemorative photos from our event. Thank you to all the speakers and participants for making the 2018 seminar a success. See you next year!
The Westin Immunogenicity Seminar is a unique forum for industry and academic professionals to share ideas, present research updates, and network with potential collaborators. The purpose of this seminar is to bridge the gap between protein drug development and recent academic research on Tregs, Tregitopes, with a special focus on immunogenicity, deimmunization, and tolerance induction. This catered event takes place at the beautiful Westin Tokyo.
Confirmed keynote speakers, in order, are to include:
Bruce Mazer, MD
Professor, Department of Pediatrics, McGill University
Interim Executive Director and CSO
Research Institute of the McGill University Health Centre (RI-MUHC)
Inducing Tolerance through Peripheral Tregs: The Role of IgG and Antigen Presenting Cells
Tomoyuki Igawa, PhD
CEO and Research Head, Chugai Pharmabody Research
Double Trouble: Preclinical Path to Development of Bispecifics for Hemophilia and Cancer
Shunsuke Chikuma, PhD
Lecturer, Department of Microbiology and Immunology
Keio University School of Medicine
PD-1 and T cell tolerance: Cancer immunity, potential combination therapy and prevention of autoimmunity
Annie De Groot, MD
Research Professor and Director, Institute for Immunology and Informatics (iCubed)
The Ancer to Cancer: Pipeline for Personalized Cancer Vaccines / Rationale and Preclinical Results
Discussion topics are to include:
- Determinants of Immunogenicity
- Induction of Tolerance
- Measuring and Modulating Immunogenicity
- Immunogenicity and Tolerance in Immuno-Oncology Applications
Breakfast and a box lunch will be provided to attendees, and the seminar will be followed by a networking cocktail hour.
The full agenda can be found below.
For more information, please contact Sarah Moniz at firstname.lastname@example.org.